Table III.
Comparison of surgical timing and seniority of lead surgeon.
| Category | 2019 | 2020 | Chi-squared test | p-value |
|---|---|---|---|---|
| Total FFF, n | 113 | 121 | ||
| Time to theatre, n (%) | < 0.001* | |||
| < 1 day | 68 (60.2) | 103 (85.1) | ||
| 2 days | 32 (28.3) | 11 (9.1) | ||
| ≥ 3 days | 13 (11.5) | 7 (5.8) | ||
| Surgeon seniority | χ2(2) = 23.43 | < 0.001† | ||
| Consultant (led/supervised Supervised Trainer Scrubbed (STS) / Supervised Trainer Un-Scrubbed (STU)) | 50 (44.2) | 92 (76.0) | ||
| Non-consultant | 63 (55.8) | 29 (24.0) | ||
| Total non-FFF, n | 491 | 279 | ||
| Time to theatre, n (%) | < 0.001* | |||
| < 1 day | 372 (75.7) | 243 (86.7) | ||
| 2 days | 23 (4.7) | 8 (2.9) | ||
| ≥ 3 days | 96 (19.6) | 28 (10.4) | ||
| Surgeon seniority | χ 2(2) = 17.12 | < 0.001† | ||
| Consultant (led/supervised STS/STU) | 351 (71.5) | 237 (84.9) | ||
| Non-consultant | 140 (28.5) | 42 (15.1) |
*
Kruskal-Wallis test.
†
Chi-squared test.
FFF, femoral fragility fractures; STS, consultant supervised trainer scrubbed; STU, consultant supervised trainer unscrubbed in theatre.